Jul 25, 2024
In this episode, host Shikha Jain, MD, speaks
with Shyam Natarajan, PhD, about machine learning
in cancer research and testing, using technological innovation to
address disparities in health care trials and more.
• Welcome to another exciting episode of Oncology
Overdrive 1:17
• About Natarajan 1:22
• The interview 2:10
• How did you get into the medical technology space?
2:29
• Can you explain what machine learning means?
4:37
• How did you end up co-founding Avenda Health?
7:18
• Do you think that this type of technology is
replicable in other disease types as well? […] Where else do you
see this being a benefit? 9:53
• When you think about AI, what are the other
applications for this type of technology outside of oncology?
11:24
• How do you respond to concerns that AI is becoming
too sentient or independent?
12:50
• What are the checkpoints we need to put in place to
make sure that biases in AI algorithms do not become the norm?
16:21
• Do you have ways to predict who would benefit from
these types of technology, and can you categorize patients into who
is appropriate for trialing these technologies?
19:44
• Is there a way to utilize this technology to address
disparities in health care?
22:04
• Have you found that there are specific things that
make it harder to enroll patients in these particular clinical
trials? How do you navigate those?
24:47
• If you had a crystal ball that could see fifty years
into the future, where do you see all of this technology going?
27:28
• If someone could only listen to the last few minutes
of this episode, what would you want them to take away?
30:56
• How to contact Natarajan
31:31
• Thanks for listening
32:22
Shyam Natarajan, PhD, is the co-founder and CEO of
Avenda Health, a medtech company focused on improving outcomes for
the one in seven men at risk for prostate cancer.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com.
Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/.
Follow Dr. Jain on X:
@ShikhaJainMD. Natarajan can be reached at www.avendahealth.com or via
LinkedIn.
Disclosures: Jain and Natarajan report no relevant
financial disclosures.